Pell Bio-Med Technology Co., Ltd. (TPE:6949)

Taiwan · Delayed Price · Currency is TWD

1,490.00

+135.00 (9.96%)

Aug 26, 2026, 12:57 PM CST

Pell Bio-Med Technology Financials Overview

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	28.93	31.42	19.63	18.03	17.16	13.98
Revenue Growth	5.45%	60.07%	8.86%	5.11%	22.75%	-
Gross Profit	-10.42	-4.39	-12.33	-26.14	-11.26	-4.37
Operating Income	-497.54	-467.35	-413.5	-411.25	-236.11	-195.96
Net Income	-435.85	-423.94	-389.42	-398.76	-230.13	-188.96
Earnings Per Share	-7.03	-7.23	-6.83	-8.62	-5.87	-5.68
EPS Growth	-	-	-	-	-	-

Revenue by Segment

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cell Products	27.54	22.27	18.08	17.52	16.07	13.56
Other	1.39	1.55	1.55	0.51	1.09	0.42
Consultancy Services	-	7.6	-	-	-	-
Total	28.93	31.42	19.63	18.03	17.16	13.98

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	2,269	657.7	936.18	1,106	708.4	115.78
Total Debt	130.13	237.27	364.82	172.56	202.63	135.6
Net Cash (Debt)	2,139	420.43	571.36	933.27	505.77	-19.82
Net Cash Growth	421.13%	-26.41%	-38.78%	84.52%	-	-
Net Cash Per Share	34.49	7.17	10.01	20.17	12.89	-0.60

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-400.03	-281.29	-260.12	-179.99	-160.98	-107.84
Capital Expenditures	-227.2	-226.41	-263.79	-16.49	-6.5	-14.48
Free Cash Flow	-627.23	-507.7	-523.91	-196.48	-167.48	-122.32
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	-36.01%	-13.97%	-62.79%	-144.96%	-65.61%	-31.27%
Operating Margin	-1719.94%	-1487.24%	-2106.35%	-2280.52%	-1376.17%	-1402.03%
Pretax Margin	-1657.96%	-1440.53%	-2012.71%	-2225.02%	-1347.99%	-1351.93%
Profit Margin	-1506.68%	-1349.09%	-1983.67%	-2211.26%	-1341.32%	-1351.93%
FCF Margin	-2168.24%	-1615.65%	-2668.77%	-1089.53%	-976.14%	-875.12%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 26, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PS Ratio	3068.99	638.42	240.56	-	-	-